UCN2 and idiopathic inflammatory myopathy: In conclusion, our findings provide more evidence that the coexistence of anti-SRP antibodies and another one MSA may lead to various clinical symptoms, which may mainly cause by one of the MSAs, namely the responsible antibody, or interact in a complex syndrome, thus expanding the clinical spectrum of idiopathic inflammatory myopathy.